RAP1GAP and cancer: It is found that Rap1GAP was down-regulated in many cancers, such as breast cancer [13], squamous cell carcinoma [10, 12, 14, 15], pancreatic cancer [11], renal cell carcinoma [8], thyroid cancer [7, 16–18], gastric cancer [19, 20], and colorectal cancer [21].